Ticker Details
Bicara Therapeutics Inc. Common Stock
IPO Date:	September 13, 2024
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$821.18M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.55 | 3.61%
Avg Daily Range (30 D):	$0.45 | 2.66%
Avg Daily Range (90 D):	$0.48 | 2.89%

Institutional Daily Volume
Avg Daily Volume:	.47M
Avg Daily Volume (30 D):	.33M
Avg Daily Volume (90 D):	.52M

Trade Size
Avg Trade Size (Sh.):	73
Avg Trade Size (Sh.) (30 D):	53
Avg Trade Size (Sh.) (90 D):	64

Institutional Trades
Total Institutional Trades:	379
Avg Institutional Trade:	$1.53M
Avg Institutional Trade (30 D):	$1.01M
Avg Institutional Trade (90 D):	$1.65M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.52M
Avg Closing Trade (30 D):	$.99M
Avg Closing Trade (90 D):	$1.37M
Avg Closing Volume:	102.55K

News

Dec 15, 2025 @ 1:00 PM Bicara Therapeutics to Present at the J.P. Morgan ... Source: Claire Mazumdar

Dec 6, 2025 @ 1:00 PM Bicara Therapeutics’ Preliminary Phase 1b E... Source: Bicara Therapeutics

Oct 27, 2025 @ 12:30 PM Nanomedicine Breakthrough Technology Redefining Dr... Source: Prnewswire

Jun 1, 2025 @ 5:12 PM Bicara Therapeutics Demonstrates Deep and Durable ... Source: N/A

May 22, 2025 @ 9:00 PM Bicara Therapeutics Announces Publication of an Ab... Source: N/A

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$5.37	$-.67	$-.5
Diluted EPS	$5.37	$-.67	$-.5
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-121.52M	$-36.33M	$-27.39M
Operating Income / Loss	$-141.12M	$-40.68M	$-32.02M
Cost of Revenue
Net Cash Flow	$-349.09M	$-318.04M	$M
PE Ratio	2.82